Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-06-01
2000-07-04
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31357
Patent
active
060839759
ABSTRACT:
This invention relates to novel substituted 1,4-benzodioxine compounds having antidiabetic, antihyperglycemic, and antiobesity properties represented by the formula ##STR1## wherein R.sup.1 and R.sup.6 are independently hydrogen, C.sub.1 to C.sub.6 alkyl, trifluoromethyl, cyano, C.sub.1 to C.sub.6 alkoxy, or halogen;
REFERENCES:
patent: 5061727 (1991-10-01), Bloom
patent: 5482971 (1996-01-01), Epstein
Bloom et al., J. Med. Chem. 1992, vol. 35, No. 16, pp. 3081-3084.
Bloom et al., Drugs of the Future, 1994, vol. 19(1), 23-26.
Emorine et al., Science, 1989, vol. 245, No. 8, pp. 1118-1121.
Largis et al., Drug Development Research, 1994, vol. 32, 69-76.
American Home Products
Moran Daniel B.
Spivack Phyllis G.
LandOfFree
Substituted benzo[1,4]dioxines as antiobesity agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzo[1,4]dioxines as antiobesity agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzo[1,4]dioxines as antiobesity agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486954